i.lindholm
Submits third-party assay reports on material purchased directly. Based in Trondheim.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.69%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043133 | BPC-157 | SSA | SSA-2601-N6863 | Janoshik | 2026-Q2 | 98.37 | 4.34 | 106.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043175 | Tirzepatide | GL Biochem | GLBI-2510-N7555 | PeptideMeter | 2026-Q1 | 96.95 | 2.66 | 101.6 | Buyer-sourced | 1 | FAIL |
| AX-2026-041541 | Tirzepatide | QSC | QSC-2511-N6404 | VendorInvestigate | 2026-Q1 | 99.12 | 2.57 | 105.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019115 | Retatrutide | GSP | GSP-2411-B2857 | PeptideMeter | 2025-Q2 | 97.49 | 7.38 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018908 | CJC-1295 with DAC | TFS | TFS-{CAT}-1220 | PeptideMeter | 2025-Q2 | 98.68 | 4.38 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018999 | Hexarelin | ASY | ASY-{CAT}-1786 | Janoshik | 2025-Q1 | 99.75 | 4.22 | 93.1 | Buyer-sourced | 0 | PASS |
| AX-2025-019945 | AOD-9604 | HJ | HJ-2502-E7144 | Medutest | 2025-Q1 | 98.71 | 1.93 | 96.1 | Buyer-sourced | 0 | PASS |
| AX-2024-004224 | Liraglutide | WWB | WWB-2406-R3462 | Medutest | 2024-Q3 | 98.87 | 2.45 | — | Buyer-sourced | 1 | FAIL |